Insperity, INC
Market Movers (8-K)
NYSE
Insperity announced its second quarter 2026 financial results, showing a significant increase in net income and adjusted EBITDA, alongside a slight decrease in worksite employees.
NYSE
Insperity, Inc. stockholders approved an increase of 1.62 million shares for its Incentive Plan and re-elected directors at the 2026 Annual Meeting.
NYSE
Insperity reported Q1 2026 revenue of $1.9 billion with adjusted EPS of $1.31, highlighting progress in margin recovery efforts.
NYSE
Insperity, Inc. reported a net loss for both the fourth quarter and full year 2025, alongside an internal reorganization eliminating approximately 4% of non-sales positions.
Worse than expected
NYSE
Insperity, Inc. amended its credit agreement, increasing its revolving credit facility to $750 million and extending the maturity date to December 15, 2028.
Capital raise
NYSE
Insperity, Inc. announced a net loss for Q3 2025 and updated its full-year guidance, while also securing a multi-year extension with UnitedHealthcare for cost savings and reduced risk.
Worse than expected
Quarterly Earnings (10-Q)
NYSE
Insperity reports a net loss of $20 million in Q3 2025 and a 74% decline in year-to-date net income, driven by higher direct costs despite revenue growth.
Worse than expected
NYSE
Insperity, Inc. experienced a sharp decline in net income and diluted EPS for the second quarter and first half of 2025, primarily driven by increased health insurance and payroll tax costs, despite modest revenue and worksite employee growth.
Worse than expected
Capital raise
NYSE
Insperity's Q1 2025 shows revenue growth but a decline in net income and EPS due to increased direct costs, particularly in health insurance.
Worse than expected
NYSE
Insperity's Q3 2024 results show a significant decrease in net income and earnings per share, despite a slight increase in revenue, due to rising operating expenses and direct costs.
Worse than expected
NYSE
Insperity's second quarter saw a significant increase in net income and adjusted earnings per share, despite a slight decrease in the average number of worksite employees (WSEEs).
Worse than expected
NYSE
Insperity's first quarter of 2024 saw a decrease in net income and diluted earnings per share, alongside a slight decline in average worksite employees (WSEEs) and increased operating expenses.
Worse than expected
Annual Reports (10-K)
NYSE
Insperity's 2024 results show a decrease in net income and adjusted EBITDA despite a slight revenue increase, driven by strategic investments and rising operating expenses.
Worse than expected
NYSE
Insperity, Inc. has filed its annual report on Form 10-K for the year ended December 31, 2023, outlining its business operations, financial results, and strategic direction.
Worse than expected
Insider Trading (Form 4)
NYSE
Insperity, Inc. Chairman and CEO Paul J. Sarvadi acquired 233,000 shares of common stock at a weighted average price of $34.05.
NYSE
Philip W. Wilmington, a Director at Insperity, Inc., received an annual award of restricted stock units valued at $0, with 6,201 units vesting on the earlier of the first anniversary of the award or the next annual stockholder meeting.
NYSE
Insperity, Inc. Director Latha Ramchand was granted restricted stock units under the company's compensation plan.
NYSE
John M. Morphy, a Director at Insperity, Inc., was granted 6,201 restricted stock units under the company's Directors Compensation Plan.
NYSE
Insperity, Inc. Director Ellen H. Masterson acquired 6,201 shares of common stock through an annual award of restricted stock units.
NYSE
Director Randall Mehl of Insperity, Inc. acquired 6,201 shares of common stock through an annual restricted stock unit award.
Proxy Statements (Def-14A)
NYSE
Insperity is asking stockholders to approve an amendment to its incentive plan to increase the number of shares available for issuance by 620,000.
Worse than expected
NYSE
Insperity is asking stockholders to approve an amendment to its Certificate of Incorporation to provide limited liability protection for certain officers, similar to existing protections for directors.
Worse than expected
Schedule 13G - Passive Investments
NYSE
Investment adviser EARNEST Partners, LLC has reported a 5.4% beneficial ownership stake in Insperity, Inc. as of March 31, 2026.
NYSE
Invesco Ltd. has reported beneficial ownership of 6.4% of Insperity Inc.'s common stock as of March 31, 2026.
NYSE
Vanguard Portfolio Management has reported beneficial ownership of 5.78% of Insperity Inc.'s common stock as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G for Insperity Inc., reporting 0% beneficial ownership due to an internal reporting realignment.
NYSE
Reinhart Partners, LLC has disclosed an increased beneficial ownership of 7.3% in Insperity, Inc., holding 2,745,035 common shares.
NYSE
Mawer Investment Management Ltd. has filed an amendment to its Schedule 13G, reporting a 3.18% beneficial ownership stake in Insperity, Inc. as of December 31, 2025.